Supplements
garlic decreases gastric cancer risk
In plain terms: Does garlic prevent cancer?
Part of: 🧪 Garlic
The strongest evidence says no. Weaker studies (case-control) suggest garlic-eaters get less stomach cancer, but that benefit vanishes in higher-quality cohort studies, and the one long-term trial found garlic did nothing — only treating the H. pylori bacteria helped. The apparent link looks like study bias.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
The popular 'garlic prevents cancer' idea is **not supported by the strongest evidence**. Case-control studies show a protective association, but it **collapses to null in prospective cohort studies**, and the one long-term RCT (the Shandong Intervention Trial) found garlic did NOT significantly reduce gastric cancer — only H. pylori antibiotic treatment did. The signal looks like observational bi
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Fleischauer AT et al. 2000 · Am J Clin Nutr | observational | supports | moderate | Landmark meta: colorectal RR 0.69, stomach 0.53 - but authors flag heterogeneity, publication bias (p=.049), confounding by total vegetables. |
| Kodali RT, Eslick GD 2015 · Nutr Cancer | meta-analysis | supports | moderate | Meta (mostly case-control; 8,621 cases): high garlic intake OR 0.49 for gastric cancer - but the pooled effect is case-control-driven. |
| Li WQ et al. 2018 · Helicobacter | meta-analysis | contradicts | moderate | Meta 18 studies (142,921): OR 0.51 overall BUT NULL when restricted to prospective cohorts (OR 0.95) - the protective signal is case-control bias. |
| Ma JL et al. 2012 · J Natl Cancer Inst | RCT | contradicts | high | Shandong Intervention Trial, 14.7-yr RCT (n=3,365): 7.3 yr garlic supplementation did NOT significantly reduce gastric cancer; only H. pylori antibiotic treatment did. |
| Zhu B et al. 2014 · Clin Gastroenterol Hepatol | observational | contradicts | high | Meta prospective cohorts ONLY: colorectal RR 1.06 (null); garlic SUPPLEMENTS RR 1.18 (increased risk) - protective signal reverses in cohorts. |
| Hu JY et al. 2014 · World J Gastroenterol | observational | tested-null | high | Meta prospective cohorts only: colorectal garlic RR 1.06 (null); supplements 1.12 (ns) - confirms cohort null. |
| Chiavarini M et al. 2016 · Public Health Nutr | observational | tested-null | high | Meta: colorectal pooled OR 0.93 (ns); case-control 0.63 (protective) vs cohort null - textbook design split. |
| Wang Y et al. 2022 · Oncol Lett | meta-analysis | supports | low | Observational meta/review: garlic associated with lower gastric (OR 0.65) and colorectal (OR 0.75) cancer; all observational, mechanism-heavy. |
| Wan Q et al. 2019 · Food Sci Nutr | meta-analysis | supports | low | Umbrella review: allium/garlic intake associated with lower gastric cancer (RR 0.78) - pooled observational meta-analyses of varying quality. |
| Zhang N et al. 2022 · Iran J Public Health | observational | supports | low | Meta 17 studies: breast cancer garlic RR 0.77 (case-control-heavy; authors call for prospective studies). |
| Guercio V et al. 2015 · Mol Nutr Food Res | observational | supports | moderate | Meta: upper-aerodigestive-tract cancer garlic RR 0.74 (case-control); relation 'unclear in cohorts'. |
| Turati F et al. 2014 · Mol Nutr Food Res | meta-analysis | tested-null | moderate | Meta 16 observational (colorectal): borderline RR 0.85 overall, but cohort-only subgroup NULL (0.99) vs case-control 0.76. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.